ENVERIC BIOSCIENCES, INC. Goodwill, Acquired During Period
ENVERIC BIOSCIENCES, INC. (ENVB) reported Goodwill, Acquired During Period of $9.83 million for the 12-month period ending 2021-12-31, per its 10-K/A filed 2023-06-09.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-06-09
- ENVERIC BIOSCIENCES, INC. goodwill, acquired during period for fiscal 2021 was $9.83M.
| Period end | Goodwill, Acquired During Period 12 month |
|---|---|
| 2021-12-31 | $9.83M 10-K/A · filed 2023-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |